Hoekstra, W. J., Hargrove, T. Y., Wawrzak, Z., da Gama Jaen Batista, D., da Silva, C. F., Nefertiti, A. S. G., . . . Lepesheva, G. I. (2016). Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi. Antimicrob Agents Chemother.
Citação norma ChicagoHoekstra, William J., et al. "Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex With the Target Enzyme CYP51 From Trypanosoma Cruzi." Antimicrob Agents Chemother 2016.
Citação norma MLAHoekstra, William J., et al. "Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex With the Target Enzyme CYP51 From Trypanosoma Cruzi." Antimicrob Agents Chemother 2016.